Clinical effect of estrogen combined with metformin in the treatment of adolescent polycystic ovary syndrome

Miaomiao YU,Yanmei ZHANG,Jieming DANG,Qiuming ZHOU
DOI: https://doi.org/10.3969/j.issn.1672-1993.2017.04.013
2017-01-01
Abstract:Objectives:To evaluate the clinical effect of estrogen combined with metformin in the treatment of adolescent polycystic ovary syndrome (PCOS).Methods:95 patients with adolescent PCOS in our hospital from January 2014 to November 2015 were chosen and divided into observation group (48 cases) and control group (47 cases) randomly.The control group was treated with single medicine of estrogen,while the observation group was treated with estrogen and mefformin.The changes in sex hormone index and metabolic index before and after treatment in the two groups were compared and the clinical curative effect and adverse reactions were evaluated in the two groups.Results:After treatment,the sex hormone index (T,FSH,LH,DHEAS) of the two groups were lower than those before treatment,the level of SHBG was higher than that before treatment,and the indexes of the observation group were better than those of the control group (P < 0.05).After treatment,the metabolic indexes (FBS,TG,FIN) in the observation group were significantly lower than those of before treatment and those of the control group,and the level of HDL-C was significantly increased (P < 0.05).The total effective rate of the observation group and the control group were 91.67% and 72.24% respectively (P <0.05).There was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05).Conclusion:Estrogen and metformin is effective in treating patients with adolescent PCOS,through effectively controlling the levels of sex hormones and metabolic hormones.With remarkable effect,it is worth popularizing.
What problem does this paper attempt to address?